Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | J. H. Strickler, J. J. Nemunaitis, C. D. Weekes, R. K. Ramanathan, E. Angevin, D. Morgensztern, Rebecca Suk Heist, T. Michael Bauer, P. Kaminker, X. Fan, Sara Siggelkow, Shekman Wong, Edward B. Reilly, Daniel E. Afar, Louie Naumovski, Karen Kelly | ||||||||||||
Title | Phase 1, open-label, dose-escalation and expansion study of ABBV-399, an antibody drug conjugate (ADC) targeting c-Met, in patients (pts) with advanced solid tumors. | ||||||||||||
|
|||||||||||||
URL | http://meetinglibrary.asco.org/content/164513-176 | ||||||||||||
Abstract Text | J Clin Oncol 34, 2016 (suppl; abstr 2510) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|